Nucleic Acid Isolation And Purification market COVID-19 Impact, Trends & Business Statistics By 2030

Posted by Mrudula Anil Karmarkar on June 17th, 2024

San Francisco, 17 June 2024: The Report Nucleic Acid Isolation And Purification Market Size, Share & Trends Analysis Report By Product, By Type, By Application, By Method, By End-use, By Region, And Segment Forecasts, 2024 - 2030

The global nucleic acid isolation and purification market size is anticipated to reach USD 9.8 billion by 2030, expanding at a CAGR of 9.24% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to the increasing number of cancer cases, chronic diseases prevalence, and rising public-private funding for biotechnology and life sciences research. In addition, advancements in automation and technology, and growing demand for genetically modified crops and organisms also contribute to the market growth. For instance, in December 2023, HiMedia Labs elaborated the significance and efficacy of magnetic bead-based systems in nucleic acid extraction and applying nucleic acid isolation and purification in various end-use industries.

The number of precision medicines developed for treating multiple diseases, such as diabetes, cancer, rheumatoid arthritis, neurological diseases, and autoimmune diseases. This market is introduced with the various new approaches, aiding the manipulation of genes. For instance, the companies are investing in a platform that delivers nucleic acids, such as small interfering RNAs (siRNAs), to address gene overexpression and mutations in conditions such as cancer, genetic disorders, and autoimmune diseases. Researchers are constantly trying to find effective therapeutics for patients. The upcoming new precision therapies may hold the key to treat incurable diseases. The use of nucleic acids and nucleic acid isolation & purification products and technologies are, therefore, very crucial for developing precision medicines.

The research and development (R&D) efforts in human genomics conducted by pharmaceutical and biotechnology companies have significantly transformed disease diagnosis and treatment development. The nucleic acid isolation and purification kits and instruments market is crucial in new drug discovery, target identification, and testing, particularly in genome editing. Substantial investments in R&D and drug discovery projects drive the competitive rivalry among companies in this space. The increasing adoption of emerging technologies for therapy development is expected to further drive market growth, with nucleic acid isolation and purification serving as a key step in manufacturing drugs and therapies through recombinant genetics. Key factors contributing to growth include the widespread use of CRISPR technology for identifying and validating therapeutics, creating improved animal testing models, and reducing the cost of research and development for drug discovery in preclinical trials.

The market expansion is fueled by several factors, such as the rise in adoption of sequencing platforms for clinical diagnostics, growth in genomics & enzymology-based research, and increase in investments in R&D. The potential of molecular biology and advancement in precision medicine are further augmenting market growth. Increasing efforts of market participants to strengthen the manufacturing capacity is facilitating market expansion. For instance, in January 2023, Agilent Technologies announced an investment of USD 725 million to increase the manufacturing capacity of therapeutic nucleic acids.

Request sample report of Nucleic Acid Isolation And Purification Market@ https://www.grandviewresearch.com/industry-analysis/nucleic-acid-solation-and-purification-market/request/rs1

The incidence of genetic disorders, cancer, and infectious diseases has been growing globally for the past few years. Disorders such as thalassemia, sickle cell anemia, and cystic fibrosis are caused by genetic aberrations in an individual’s DNA. Studying nucleic acids helps gain insights into these diseases. The race for developing cost-effective, point-of-contact testing kits and efficient laboratory procedures for detecting COVID-19 infection has driven a new scope of diagnostic innovation. An increase in the adoption of PCR for SARS-CoV-2 detection by a broad range of commercial laboratories drives the market, as nucleic acid isolation & purification is a significant step in the PCR workflow.

Nucleic Acid Isolation And Purification Market Report Highlights

• Based on product, kits & reagents dominated the market with a revenue share of more than 72.0% in 2023, owing to the growing demand for kits for DNA/RNA extraction and purification
• The instruments segment is expected to grow at a significant CAGR over the forecast period
• Based on type, the DNA isolation and purification segment held the largest revenue share in 2023, owing to its variety of applications in the molecular biology field
• The RNA isolation and purification segment is anticipated to witness a significant growth over the forecast period. The growth is attributed to its applications in gene expression profiling, sequencing, and clinical diagnostics
• Based on application, the diagnostic segment led the market in 2023, owing to the rising application of DNA and RNA isolation for identifying pathogens in routine sample processing
• The drug discovery & development segment is expected to grow at the fastest CAGR from 2024 to 2030, due to the increasing number of chronic diseases and other disorders
• Based on method, the magnetic beads segment led the market in 2023. This can be attributed to its high efficacy and applications in a variety of fields
• The column-based segment is expected to register a significant growth rate during the forecast period
• Based on the end-use, the hospitals and diagnostics centers segment held the largest revenue share in 2023. The growth is due to the increased use of nucleic acid in a broad range of healthcare segments
• The pharmaceutical and biotechnology companies segment is expected to register the fastest CAGR during the projected period
• Based on region, North America dominated the NAIP market owing to factors such as leveraged government support, a favorable regulatory framework, and consistent R&D efforts
• Asia Pacific is expected to grow at the fastest CAGR during the forecast period, due to several business initiatives undertaking in countries such as China, Japan, and India
• In December 2023, Thermo Fisher Scientific Inc. launched an automatic nucleic acid purification instrument, Thermo Scientific KingFisher Apex Dx, and Applied Biosystems MagMAX Dx Pathogen/Viral NA Isolation Kit to isolate and purify bacterial and viral pathogens from biological samples

The biotechnology industry is also marked with advancements and innovations. Diagnostic tests have become more cost-effective and easier to use. The companies are investing to advance the DNA isolation process. For instance, in August 2023, Gold Standard Diagnostics (GSD) announced the launch of iMAGo PREDigest. This kit completes GSD's whole DNA isolation portfolio, delivering an automated (iMAGo Food) and manual (GeneSpin) solution with respective pre- and post-treatment offerings for difficult matrices. Automated and advanced instruments have entered the market with faster, more consistent, and cleaner processes. For instance, Thermo Fisher Scientific offers an Automated Nucleic Acid Extraction Workstation that uses revolutionary magnetic separation technology.

The nucleic acid isolation and purification market growth stage is high and the pace is accelerating. The NAIP market is characterized by a moderate to high degree of innovation due to rapid advancements and innovations in the biotechnology industry. It utilizes molecular detection platforms, robotic liquid handling technology, droplet digital PCR, NGS, and genome-wide sequencing, among others in effective extraction and purification of nucleic acid.

Nucleic Acid Isolation AND Purification Market Report Scope

The nucleic acid isolation & purification market is further characterized by a moderate level of merger and acquisition (M&A) activity by the leading players. This is due to several factors, including the desire to gain access to new nucleic acid isolation & purification facilities, increase their capabilities, expand product portfolios, and improve competencies.

The NAIP market is also subject to substantial regulatory scrutiny. Manufacturers and suppliers of nucleic acid isolation and purification kits and instruments must comply with various regulations, such as those related to genomics, forensics, molecular diagnostics, and genetic engineering.

List of Key Players in the Nucleic Acid Isolation And Purification Market

• QIAGEN
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Danaher
• F. Hoffmann-La Roche Ltd
• Merck KGaA
• Agilent Technologies
• Bio-Rad Laboratories, Inc.
• Takara Bio Inc.